Clinical Trial Update: Study to Investigate Effect of a New Drug (PF-00446687) in Males Suffering From Erectile Dysfunction [Phase 2]

View source ↗

Summary

Pfizer completed a Phase 2 trial evaluating PF-00446687 for erectile dysfunction in men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• PF-00446687

Snippet

Sponsor: Pfizer | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED